Okay, let's tackle this question about the drug of choice for Clostridium difficile-induced colitis. First, I need to recall what C. difficile is. It's a bacterium that causes inflammation of the colon, often after antibiotic use disrupts normal gut flora. The main treatment is antibiotics that target C. difficile specifically.

The options aren't listed, but the correct answer is probably one of the standard treatments. Common options include metronidazole, vancomycin, or fidaxomicin. I remember that metronidazole was previously first-line for mild to moderate cases, but maybe there's a newer drug now. Fidaxomicin has been shown to reduce recurrence rates compared to vancomycin, but it's more expensive. Vancomycin is often used for severe cases or when metronidazole isn't suitable.

Wait, the question is about the drug of choice. I think the current guidelines might favor fidaxomicin over vancomycin for the first episode due to lower recurrence, but in many settings, vancomycin is still used. However, metronidazole is not recommended as first-line anymore because of resistance concerns. So the correct answer is likely fidaxomicin or vancomycin. But if the options include both, which one is preferred? Also, sometimes the question might be testing the knowledge that fidaxomicin is the newer drug with better outcomes.

I need to make sure about the current guidelines. The CDC and IDSA guidelines recommend fidaxomicin as an alternative to vancomycin for first episodes, especially in patients with recurrence risk. So if the options include fidaxomicin, that's the answer. If not, vancomycin is next. But since the correct answer is given as an option, I need to structure the explanation around that.

Now, the explanation should mention the mechanism of action, maybe the enzyme targets. Fidaxomicin inhibits bacterial RNA polymerase, which is specific to C. difficile. Vancomycin is a glycopeptide that inhibits cell wall synthesis. Metronidazole is a nitroimidazole that's activated by anaerobic bacteria, but resistance has been reported.

For the wrong options: if the options include tetracycline, clindamycin, or others, those are incorrect because they can worsen the infection. Also, if metronidazole is an option, it's not the first-line anymore. So each wrong option needs a reason why it's not correct.

The clinical pearl would be to remember fidaxomicin or vancomycin as first-line, depending on context. Also, the importance of stopping the inciting antibiotic.

Putting it all together, the correct answer is likely fidaxomicin or vancomycin. The explanation should clarify why one is preferred over the other, based on guidelines and recurrence rates. Need to check if the question is from a specific year, but since it's a general question, stick to the latest consensus.

**Core Concept**
Clostridium difficile infection (CDI) is a major cause of antibiotic-associated colitis, characterized by pseudomembranous colitis. The drug of choice must specifically target C. difficile while minimizing recurrence, resistance, and collateral damage to gut microbiota. Current guidelines prioritize agents with high efficacy against toxin-producing strains and low recurrence rates.

**Why the Correct Answer

✓ Correct Answer: C. Oral Vancomycin